Factor Viii Inhibitor Bypassing Fraction

3 trials 2 recruiting BHaematology

Filter these 3 trials by condition, phase, country and more.

Open in Search →

3 Registered trials

2 Recruiting

1 Completed trials

4 Sponsors

13 Countries

Phase III

Phase IV

Phase III: 2 Phase IV: 1

Indications tested

Von Willebrand´s disease 1

Sponsors using this IMP

Emory University 1 F. Hoffmann-La Roche AG 1 HZRM Haemophilie-Zentrum Rhein Main GmbH 1 Sanofi-Aventis Recherche & Developpement 1

All trials

3 total

A Study to assess safety and effectiveness of Emicizumab in Patients with Type 3 Von Willebrand Disease Recruiting

2024-515622-80-00 Phase III 8 countries F. Hoffmann-La Roche AG
An international investigator initiated trial to capture different approaches in the treatment of Haemophilia A Patients With FVIII Inhibito… Recruiting

2024-516741-39-00 Phase IV 7 countries Emory University; HZRM Haemophilie-Zentrum Rhein Main GmbH
A study to test a medicine (fitusiran) injected under the skin for preventing bleeding episodes in male adolescent or adult participants wit… Ended

2022-500221-33-01 Phase III 6 countries Sanofi-Aventis Recherche & Developpement

Showing 1–3 of 3 trials

← All drugs A–Z